subject: UNII:5TAA004E22

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Locally Advanced Triple-Negative Breast Carcinoma

tested_intervention: unsure


subject: UNII:5TAA004E22

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Merkel Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Hepatocellular Carcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Unresectable Renal Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IV Cervical Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Unresectable Breast Carcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Unresectable Cervical Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Unresectable Malignant Solid Neoplasm


subject: UNII:5TAA004E22

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:5TAA004E22

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: UNII:5TAA004E22

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Endometrial Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Skin Squamous Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Metastatic Endometrial Carcinoma


subject: UNII:5TAA004E22

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Skin squamous cell carcinoma metastatic


subject: UNII:5TAA004E22

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: UNII:5TAA004E22

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:5TAA004E22

object_name: Unresectable Renal Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Merkel Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Metastatic hepatocellular carcinoma


subject: UNII:5TAA004E22

object_name: Metastatic Merkel cell carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Urothelial Carcinoma


subject: UNII:5TAA004E22

object_name: Metastatic urothelial carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Gastric Adenocarcinoma


subject: UNII:5TAA004E22

object_name: skin squamous cell carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Cervical Carcinoma


subject: UNII:5TAA004E22

object_name: Metastatic gastric adenocarcinoma


subject: UNII:5TAA004E22

object_name: Metastatic Cervical Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Melanoma


subject: PR:000005931

object_name: Locally Advanced Melanoma


subject: PR:000005931

object_name: Locally Advanced Malignant Solid Neoplasm


subject: PR:000005931

object_name: Locally Advanced Renal Cell Carcinoma


subject: PR:000005931

object_name: Locally Advanced Cervical Carcinoma


subject: PR:000005931

object_name: Stage III Lung Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Urothelial Carcinoma


subject: PR:000005931

object_name: Locally Advanced Endometrial Carcinoma


subject: PR:000005931

object_name: Stage III Renal Cell Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: PR:000005931

object_name: Stage III Cervical Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Merkel Cell Carcinoma


subject: PR:000005931

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: PR:000005931

object_name: Stage IIIB Lung Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIC Lung Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIA Lung Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: PR:000005931

object_name: Locally Advanced Hepatocellular Carcinoma


subject: PR:000005931

object_name: Locally Advanced Gastric Adenocarcinoma


subject: PR:000005931

object_name: Stage IV Lung Cancer AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: PR:000005931

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: PR:000005931

object_name: Stage IVA Lung Cancer AJCC v8


subject: PR:000005931

object_name: Stage IVB Lung Cancer AJCC v8


subject: PR:000005931

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Unresectable Renal Cell Carcinoma


subject: PR:000005931

object_name: Stage IV Cervical Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Unresectable Breast Carcinoma


subject: PR:000005931

object_name: Locally Advanced Unresectable Cervical Carcinoma


subject: PR:000005931

object_name: Stage IVA Cervical Cancer AJCC v8


subject: PR:000005931

object_name: Stage IVB Cervical Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: PR:000005931

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: PR:000005931

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: PR:000005931

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: PR:000005931

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: PR:000005931

object_name: Unresectable Malignant Solid Neoplasm


subject: PR:000005931

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: PR:000005931

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PR:000005931

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: PR:000005931

object_name: Squamous cell carcinoma of head and neck metastatic


subject: PR:000005931

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: PR:000005931

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: PR:000005931

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: PR:000005931

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: PR:000005931

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: PR:000005931

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PR:000005931

object_name: Unresectable Endometrial Carcinoma


subject: PR:000005931

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: PR:000005931

object_name: Unresectable Skin Squamous Cell Carcinoma


subject: PR:000005931

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: PR:000005931

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: PR:000005931

object_name: Metastatic Endometrial Carcinoma


subject: PR:000005931

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PR:000005931

object_name: Skin squamous cell carcinoma metastatic


subject: PR:000005931

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: PR:000005931

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PR:000005931

object_name: Unresectable Renal Cell Carcinoma


subject: PR:000005931

object_name: Unresectable Hepatocellular Carcinoma


subject: PR:000005931

object_name: Unresectable Merkel Cell Carcinoma


subject: PR:000005931

object_name: Metastatic hepatocellular carcinoma


subject: PR:000005931

object_name: Metastatic Merkel cell carcinoma


subject: PR:000005931

object_name: Unresectable Urothelial Carcinoma


subject: PR:000005931

object_name: Metastatic urothelial carcinoma


subject: PR:000005931

object_name: Unresectable Gastric Adenocarcinoma


subject: PR:000005931

object_name: skin squamous cell carcinoma


subject: PR:000005931

object_name: Unresectable Cervical Carcinoma


subject: PR:000005931

object_name: Metastatic gastric adenocarcinoma


subject: PR:000005931

object_name: Metastatic Cervical Carcinoma


subject: PR:000005931

object_name: Unresectable Melanoma


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:134506

object_name: type 1 diabetes mellitus


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:5118

subject_name: Fluoxetine


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: nasopharyngeal carcinoma


subject: PR:000001151

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5391732

object_name: corticobasal syndrome

tested_intervention: yes


subject: UMLS:C5391732

object_name: Pick Complex


subject: UMLS:C5391732

object_name: frontotemporal dementia


subject: UMLS:C5391732

object_name: progressive non-fluent aphasia


subject: UMLS:C4688466

subject_name: INCMGA 0012

object_name: Resectable Sarcoma


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Hypertensive nephrosclerosis


subject: CHEBI:601027

object_name: focal segmental glomerulosclerosis


subject: CHEBI:601027

object_name: membranous glomerulonephritis


subject: CHEBI:601027

object_name: IgA Nephropathy


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:9927


subject: CHEBI:9927


subject: CHEBI:9927

object_name: diabetic kidney disease


subject: CHEBI:9927


subject: CHEBI:229764

subject_name: Selinexor

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:229764

object_name: colorectal neoplasm


subject: UNII:L2BD0MW4OL

object_name: Disseminated Malignant Neoplasm


subject: UNII:L2BD0MW4OL

object_name: Embolism, Tumor


subject: UNII:L2BD0MW4OL

object_name: Neoplasm Metastasis


subject: MESH:C000621159

subject_name: Ropren

object_name: acute coronary syndrome


subject: UMLS:C0388088

object_name: asthma


subject: CHEBI:63115

subject_name: Fingolimod


subject: UMLS:C0304604

subject_name: Topical form corticosteroids

object_name: atopic eczema


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: temporomandibular joint disorder


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: PUBCHEM.COMPOUND:56649447

subject_name: vipoglanstat

object_name: endometriosis


subject: UNII:FN57BDR4DA

subject_name: VIPOGLANSTAT


subject: UMLS:C3889729

subject_name: Carbon Nanoparticle-based Formulation

object_name: Stomach cancer


subject: UMLS:C3889729

object_name: gastric cancer


subject: CHEBI:231693

subject_name: Capmatinib

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: ovarian carcinoma


subject: UMLS:C5667079

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5667079

object_name: fallopian tube carcinoma


subject: UMLS:C5667079

object_name: fallopian tube cancer


subject: UMLS:C5667079

object_name: primary peritoneal carcinoma


subject: UMLS:C5667079

object_name: Primary Peritoneal Cancer


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: Friedreich ataxia


subject: CHEBI:17154

object_name: Friedreich ataxia 1


subject: UMLS:C4547825

object_name: long QT syndrome


subject: UMLS:C4547825

object_name: familial long QT syndrome


subject: UMLS:C4547825

object_name: Prolonged QT interval


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Pregnant


subject: UMLS:C1963284

subject_name: Adrenalin


subject: UMLS:C0729218

object_name: chronic pain (diagnosis)


subject: UMLS:C0729218

object_name: Chronic pain


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UMLS:C1699394

subject_name: Hylenex

object_name: Alzheimer disease type 1


subject: UMLS:C1699394

object_name: Alzheimer disease


subject: CHEBI:231355

subject_name: Tasquinimod

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:231355

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:233331

subject_name: Elamipretide

object_name: heart failure


subject: CHEBI:233331

object_name: Heart Failure, CTCAE


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: male breast carcinoma


subject: PUBCHEM.COMPOUND:9861622

subject_name: Ecopipam

object_name: Restless legs


subject: PUBCHEM.COMPOUND:9861622

object_name: Increased size (finding)


subject: UNII:29DKI2H2NY

subject_name: Tinostamustine

object_name: glioblastoma


subject: UNII:29DKI2H2NY

object_name: Childhood Glioblastoma


subject: UNII:29DKI2H2NY

object_name: adult glioblastoma


subject: UNII:29DKI2H2NY

object_name: MGMT-Unmethylated Glioblastoma


subject: UNII:29DKI2H2NY

object_name: Adult Gliosarcoma


subject: UNII:29DKI2H2NY

object_name: gliosarcoma


subject: UNII:29DKI2H2NY

object_name: Childhood Gliosarcoma


subject: UMLS:C0700926

subject_name: Ancef

object_name: opioid use


subject: UMLS:C0700926

object_name: no feeling or sensation of skin


subject: UMLS:C0700926

object_name: Sensory Loss


subject: CHEBI:474053

subject_name: Cefazolin


subject: CHEBI:474053


subject: CHEBI:474053


subject: UMLS:C2608320

subject_name: Aspirin Low Dose


subject: UMLS:C2608320


subject: UMLS:C2608320


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate


subject: CHEBI:6741

subject_name: Meloxicam


subject: CHEBI:6741


subject: CHEBI:4975

subject_name: Famotidine


subject: CHEBI:4975


subject: CHEBI:4975


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: PUBCHEM.COMPOUND:4715169


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:107736


subject: CHEBI:107736


subject: UMLS:C0146226

subject_name: Toradol


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: CHEBI:36088


subject: UMLS:C0042553

subject_name: Versed


subject: UMLS:C0042553


subject: UMLS:C0042553


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:7774

subject_name: Zofran


subject: CHEBI:7774


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: UMLS:C4053649

subject_name: WT1 Protein-derived Peptide Vaccine DSP-7888


subject: UMLS:C4053649


subject: UMLS:C4053649


subject: UMLS:C4053649

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C4053649

object_name: diffuse intrinsic pontine glioma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: unspecified childhood solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Childhood Central Nervous System Embryonal Tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: childhood central nervous system mixed germ cell tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: childhood central nervous system germ cell tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: Childhood Central Nervous System Embryonal Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: childhood central nervous system primitive neuroectodermal neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: central nervous system endodermal sinus tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: pediatric CNS choriocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: childhood central nervous system germinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Childhood Central Nervous System Teratoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C0033307

subject_name: Progestational Hormones, Synthetic

object_name: paroxysmal familial ventricular fibrillation


subject: UMLS:C0033307

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UMLS:C0033307

object_name: infertility


subject: CHEBI:59826

subject_name: progestin


subject: CHEBI:59826


subject: CHEBI:59826


subject: UMLS:C3536710

subject_name: Progestin [EPC]


subject: UMLS:C3536710


subject: UMLS:C3536710


subject: CHEBI:9168

subject_name: Sirolimus

object_name: benign neoplasm


subject: CHEBI:135515

subject_name: Bendamustine

object_name: high grade B-cell lymphoma


subject: CHEBI:135515

object_name: primary mediastinal large B-cell lymphoma


subject: UNII:C67ORA155P

subject_name: BRENTUXIMAB


subject: UNII:C67ORA155P

object_name: diffuse large B-cell lymphoma


subject: UNII:C67ORA155P

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: UNII:C67ORA155P

object_name: follicular lymphoma


subject: UNII:C67ORA155P


subject: UNII:C67ORA155P

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:C67ORA155P

object_name: marginal zone lymphoma


subject: UNII:C67ORA155P

object_name: MALT lymphoma


subject: UNII:7XL5ISS668

subject_name: Adcetris


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: UMLS:C1328236


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13796

object_name: breast carcinoma


subject: GTOPDB:13796

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: UMLS:C4745029


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Disorder of olfactory system


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: melanoma


subject: CHEBI:38848

subject_name: perflunafene


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: CHEBI:231683

subject_name: Anakinra

object_name: Acute pericarditis


subject: CHEBI:231683

object_name: Acute Pericarditis Related to COVID-19


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Disorder of intraocular pressure


subject: CHEBI:4466

object_name: Intraocular Pressure


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:114785

subject_name: Erlotinib

object_name: brain neoplasm


subject: UMLS:C0054599

subject_name: canola oil

object_name: cardiovascular disorder


subject: UMLS:C1815158

subject_name: Flax oil


subject: DRUGBANK:DB11357

subject_name: Linseed oil


subject: CHEMBL.COMPOUND:CHEMBL1201660

subject_name: SAFFLOWER OIL


subject: GTOPDB:13451

subject_name: vixarelimab

object_name: interstitial lung disease 1


subject: GTOPDB:13451

object_name: interstitial lung disease 2


subject: GTOPDB:13451

object_name: pulmonary systemic sclerosis


subject: UNII:W25GO3A75W

subject_name: VIXARELIMAB


subject: UNII:W25GO3A75W


subject: UNII:W25GO3A75W


subject: UMLS:C5421363

subject_name: Vixarelimab


subject: UMLS:C5421363


subject: UMLS:C5421363


subject: CHEBI:5818

subject_name: Hydroxyzine

object_name: Dyssomnias


subject: CHEBI:5818

object_name: Sleep abnormality


subject: CHEBI:5818

object_name: Stress


subject: CHEBI:5818

object_name: sleep disorder


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:84500


subject: CHEBI:84500

object_name: Nausea, CTCAE_5


subject: CHEBI:84500

object_name: Nausea


subject: CHEBI:84500

object_name: Nausea, CTCAE_3


subject: CHEBI:84500


subject: CHEBI:84500


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:41879

object_name: obesity


subject: CHEBI:41879

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:167312484


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Mycoplasma genitalium infection


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:25185057

subject_name: lefamulin


subject: UMLS:C0015491

subject_name: factor IX

object_name: blood coagulation disease


subject: UMLS:C0015491

object_name: hemorrhagic disease


subject: UMLS:C0015491

object_name: hematologic disorder


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: UNII:6073LCU8U9

object_name: pancreatic neoplasm


subject: UNII:6073LCU8U9

object_name: exocrine pancreatic carcinoma


subject: UNII:6073LCU8U9

object_name: malignant pancreatic neoplasm


subject: UNII:6073LCU8U9

object_name: malignant exocrine pancreas neoplasm


subject: UMLS:C4087049

subject_name: Lozanoc

object_name: leukopenia


subject: UMLS:C4087049

object_name: neutropenia


subject: CHEBI:41879

object_name: retinal detachment


subject: CHEBI:41879

object_name: Retinal Detachment, CTCAE 3.0


subject: CHEBI:41879

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:4672

object_name: Malignant Solid Neoplasm


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:176724

subject_name: Etiracetam

object_name: alcohol withdrawal


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6121

subject_name: Ketamine

object_name: digestive system cancer


subject: CHEBI:6121

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: disease transmission


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: Small cell lung cancer limited stage


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: pleural mesothelioma


subject: CHEBI:90001

object_name: malignant pleural mesothelioma


subject: CHEBI:90001

object_name: pleural disease


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:42797

subject_name: Gabapentin

object_name: neurotoxicity


subject: PUBCHEM.COMPOUND:53393991

subject_name: Rivenprost

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:53393991

object_name: inflammatory bowel disease 1


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C0020172

subject_name: Humulin S

object_name: Type 2 diabetes mellitus with hypoglycemia


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:52717

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:52717

object_name: Metastatic non-small cell lung cancer


subject: MESH:C000722007


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: orthopedic disorders of spine


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: metastatic melanoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:6775

subject_name: Mesalazine

object_name: microscopic colitis


subject: CHEBI:149836

subject_name: Tigecycline

object_name: bacterial pneumonia


subject: CHEBI:149836

object_name: skin disease caused by bacterial infection


subject: CHEBI:149836

object_name: cellulitis


subject: UMLS:C2603727

object_name: cancer


subject: UMLS:C2603727

object_name: neoplasm


subject: CHEBI:87681

subject_name: Ranolazine

object_name: peripheral vascular disease


subject: CHEBI:87681

object_name: peripheral arterial disease


subject: CHEBI:6121

subject_name: Ketamine

object_name: Anoperineal fistula


subject: CHEBI:31797

subject_name: Gadolinium DTPA

object_name: cardiovascular disorder


subject: CHEBI:180856

subject_name: Hovenoside G


subject: UMLS:C0721529

subject_name: Magnevist


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5206953

object_name: Solid Neoplasm


subject: UMLS:C5206815

object_name: endometrial cancer


subject: UMLS:C5206815

object_name: uterine corpus cancer


subject: UMLS:C5206815

object_name: endometrial carcinoma


subject: UMLS:C5206815

object_name: endometrium adenocarcinoma


subject: CHEBI:58432

subject_name: histaminium

object_name: skin disorder


subject: CHEBI:18295

subject_name: Histamine


subject: UMLS:C0445115

subject_name: Normal saline


subject: CHEBI:190692

subject_name: substance P(3+)


subject: CHEBI:80308

subject_name: substance P


subject: UNII:675VGV5J1D

subject_name: SUBSTANCE P


subject: UMLS:C0038585

subject_name: Substance P


subject: CHEBI:133021

subject_name: Venetoclax

object_name: primary central nervous system lymphoma


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C5784739

subject_name: EGFR Mutant-selective Inhibitor H002

object_name: non-small cell lung carcinoma


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: CD274 Gene Mutation


subject: PR:000014196

object_name: cancer


subject: PR:000014196

object_name: neoplasm


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: UMLS:C1879517

subject_name: Fas Receptor Agonist APO010


subject: UMLS:C1879517


subject: UMLS:C3275321

object_name: pancreatic neoplasm


subject: UMLS:C3275321

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3275321

object_name: malignant pancreatic neoplasm


subject: UNII:2M3055079H

subject_name: Brivudine


subject: UNII:2M3055079H


subject: UNII:2M3055079H


subject: UMLS:C2981820

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C2981820

object_name: Recurrent Glioblastoma


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:145373


subject: CHEBI:91872

object_name: neurofibromatosis 1


subject: CHEBI:91872

object_name: neurofibromatosis type 1


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: UMLS:C0370003

subject_name: Specimen

object_name: Acute Respiratory Distress


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Blastic Phase


subject: CHEBI:52717

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:52717

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:52717

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:52717

object_name: Recurrent disease


subject: CHEBI:141969

subject_name: Tipifarnib


subject: CHEBI:141969


subject: CHEBI:141969


subject: CHEBI:141969

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:141969

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:141969


subject: CHEBI:141969

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UNII:4AW7F70MZO

subject_name: Dimiracetam

object_name: AIDS


subject: CHEBI:91899

object_name: precancerous condition


subject: CHEBI:3207

subject_name: Budesonide


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: sensory peripheral neuropathy


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: carcinoid tumor


subject: CHEBI:72317

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:72317

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:72317

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C4733662

subject_name: MEK inhibitor CS3006

object_name: Adult Solid Neoplasm


subject: UMLS:C5854691

subject_name: Rezolsta

object_name: HIV infection


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: brain neoplasm


subject: CHEBI:191174

object_name: malignant neoplasm of fourth ventricle of brain


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: drug-induced dyskinesia


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Anxious mood


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:5818

subject_name: Hydroxyzine

object_name: anxiety


subject: CHEBI:5818


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:131769963

object_name: ISS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:131769963

object_name: ISS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:131769963

object_name: DS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:131769963

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Mantle cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:131769963

object_name: Mantle cell lymphoma stage III


subject: PUBCHEM.COMPOUND:131769963

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: B-cell small lymphocytic lymphoma stage IV


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: B-cell small lymphocytic lymphoma stage III


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Marginal zone lymphoma stage IV


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Marginal zone lymphoma stage III


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:131769963

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Waldenstrom macroglobulinemia


subject: UNII:5XYK65KIGD

object_name: DS Stage II Plasma Cell Myeloma


subject: UNII:5XYK65KIGD

object_name: ISS Stage II Plasma Cell Myeloma


subject: UNII:5XYK65KIGD

object_name: ISS Stage III Plasma Cell Myeloma


subject: UNII:5XYK65KIGD

object_name: DS Stage III Plasma Cell Myeloma


subject: UNII:5XYK65KIGD

object_name: Mantle cell lymphoma recurrent


subject: UNII:5XYK65KIGD

object_name: Mantle cell lymphoma stage IV


subject: UNII:5XYK65KIGD

object_name: Mantle cell lymphoma stage III


subject: UNII:5XYK65KIGD

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:5XYK65KIGD

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:5XYK65KIGD

object_name: splenic marginal zone lymphoma


subject: UNII:5XYK65KIGD

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:5XYK65KIGD

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UNII:5XYK65KIGD

object_name: Marginal zone lymphoma recurrent


subject: UNII:5XYK65KIGD

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:5XYK65KIGD

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: MALT lymphoma


subject: UNII:5XYK65KIGD

object_name: Marginal zone lymphoma stage IV


subject: UNII:5XYK65KIGD

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:5XYK65KIGD

object_name: Marginal zone lymphoma stage III


subject: UNII:5XYK65KIGD

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:5XYK65KIGD

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:5XYK65KIGD

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:5XYK65KIGD

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:50924

subject_name: Sorafenib

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:50924

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:50924

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:50924

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:50924

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:50924

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:50924

object_name: Mantle cell lymphoma stage III


subject: CHEBI:50924

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:50924

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:50924

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:50924

object_name: splenic marginal zone lymphoma


subject: CHEBI:50924

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:50924

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:50924

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:50924

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:50924

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:50924

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:50924

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:50924

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:50924

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:50924

object_name: MALT lymphoma


subject: CHEBI:50924

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:50924

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:50924

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:50924

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:50924

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:50924

object_name: Marginal zone lymphoma stage III


subject: CHEBI:50924

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:50924

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:50924

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:50924

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:50924

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:50924

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:50924

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:50924

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:50924

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:50924

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:50924

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:50924

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:50924

object_name: Waldenstrom macroglobulinemia


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: ovarian cancer


subject: UNII:4EQZ6YO2HI

object_name: ovarian carcinoma


subject: UNII:4EQZ6YO2HI

object_name: malignant epithelial tumor of ovary


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:18385

subject_name: Thiamine

object_name: Hyperlactatemia


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: Refractory Langerhans Cell Histiocytosis


subject: CHEBI:167672

object_name: Recurrent Langerhans Cell Histiocytosis


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: pelvic organ prolapse, susceptibility to


subject: CHEBI:38940

subject_name: Sunitinib

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: lip and oral cavity carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: oral cavity cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: Pleural mesothelioma malignant advanced


subject: PUBCHEM.COMPOUND:2767

object_name: Pleural mesothelioma malignant recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Peritoneal mesothelioma malignant recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Unresectable Solid Neoplasm


subject: CHEBI:192842

subject_name: Methoxyamine


subject: CHEBI:192842


subject: CHEBI:192842

object_name: malignant peritoneal mesothelioma


subject: CHEBI:192842


subject: CHEBI:192842

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:71255

subject_name: Asenapine

object_name: bipolar I disorder


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: UMLS:C1831942

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL5095039

subject_name: GALLIUM GA 68 GOZETOTIDE

object_name: Advanced Hepatocellular Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: CHEBI:7553

subject_name: Niclosamide

object_name: ulcerative colitis


subject: CHEBI:7553

object_name: ulcerative proctosigmoiditis


subject: CHEBI:7553

object_name: Ulcerative proctitis (disorder)


subject: CHEBI:7553

object_name: proctitis


subject: CHEBI:7553

object_name: Chronic ulcerative proctitis


subject: CHEBI:7553

object_name: inflammatory bowel disease 1


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Ventricular Dysfunction


subject: CHEBI:5818

subject_name: Hydroxyzine

object_name: panic disorder


subject: CHEBI:5818

object_name: panic disorder 1


subject: PUBCHEM.COMPOUND:57345449

object_name: Arrhythmia


subject: UMLS:C3177398

subject_name: DLBS 1033

object_name: Acute non-ST segment elevation myocardial infarction (disorder)


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Chronic kidney disease stage 5 on dialysis


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:68646

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:68646

object_name: PPoma


subject: CHEBI:68646

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:68646

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: CHEBI:68646

object_name: pancreatic somatostatinoma


subject: CHEBI:68646

object_name: somatostatinoma


subject: CHEBI:68646

object_name: recurrent islet cell carcinoma


subject: CHEBI:68646

object_name: lung carcinoid tumor


subject: CHEBI:68646

object_name: glucagonoma


subject: CHEBI:68646

object_name: Zollinger-Ellison syndrome


subject: CHEBI:68646

object_name: gastrinoma


subject: CHEBI:68646

object_name: pancreatic gastrinoma


subject: CHEBI:68646

object_name: insulinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: Dialysis hypotension


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: UMLS:C2717002

object_name: migraine


subject: UMLS:C2717002

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:81579

object_name: Childhood Breast Carcinoma


subject: CHEBI:81579

object_name: breast carcinoma


subject: CHEBI:81579

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL3707352

subject_name: policosanol

object_name: coronary microvascular disorder


subject: CHEMBL.COMPOUND:CHEMBL3707352

object_name: hyperlipidemia


subject: CHEMBL.COMPOUND:CHEMBL3707352

object_name: hyperlipoproteinemia


subject: CHEMBL.COMPOUND:CHEMBL3707352

object_name: Hyperlipidemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3707352

object_name: Serum lipids high (finding)


subject: UMLS:C5544403

subject_name: Secretome

object_name: acne


subject: PUBCHEM.COMPOUND:9803433

object_name: Advanced cancer


subject: UNII:9JD9B4S53T


subject: UNII:4HA45S22ZZ


subject: CHEBI:67271


subject: CHEBI:82677

subject_name: ridaforolimus


subject: UMLS:C2703210

object_name: non-small cell lung carcinoma


subject: UMLS:C2703210

object_name: KRAS Activating Mutation


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: skin melanoma


subject: CHEBI:4305

subject_name: dacarbazine


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: complex regional pain syndrome


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64312

subject_name: Memantine

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:64312

object_name: Recurrent Childhood Brain Neoplasm


subject: CHEBI:64312

object_name: Recurrent Brain Neoplasm


subject: CHEBI:64312

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:64312

object_name: metastatic melanoma


subject: CHEBI:64312

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:64312

object_name: Metastatic Lung Small Cell Carcinoma


subject: CHEBI:64312

object_name: Metastatic Malignant Breast Neoplasm


subject: CHEBI:64312

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:64312

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:64312

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:64312

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:64312

object_name: Metastatic Malignant Digestive System Neoplasm


subject: CHEBI:64312

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:S5NN2E9ZKF

subject_name: DOTMP SM-153

object_name: pediatric osteosarcoma


subject: CHEBI:3311

subject_name: Calcium carbonate


subject: CHEBI:3311

object_name: Osteosarcoma


subject: CHEBI:3311

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Premature birth


subject: PUBCHEM.COMPOUND:92043599

object_name: premature birth (history)


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UMLS:C0376541


subject: CHEBI:151315

subject_name: Heparin

object_name: Vaso-Occlusive Crisis


subject: GTOPDB:6803

subject_name: dalteparin

object_name: sickle cell disease


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: HMDB:HMDB0015666

subject_name: Lornoxicam

object_name: acute coronary syndrome


subject: UMLS:C0939527

subject_name: Viokase 16

object_name: exocrine pancreatic insufficiency


subject: CHEBI:9139

subject_name: Sildenafil

object_name: Female sexual arousal disorder


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C0003442

object_name: marginal zone lymphoma


subject: CHEBI:135515

subject_name: Bendamustine

object_name: CD20 Positive


subject: UNII:PVI5M0M1GW

object_name: follicular lymphoma


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C0005515

subject_name: Biological Factors

object_name: rheumatoid arthritis


subject: DRUGBANK:DB05173

object_name: Carcinoma breast stage IV


subject: CHEBI:17895

subject_name: Tyrosine

object_name: brain cancer


subject: CHEBI:17895

object_name: brain neoplasm


subject: PUBCHEM.COMPOUND:67395


subject: PUBCHEM.COMPOUND:67395


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Adult Gliosarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: gliosarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Childhood Gliosarcoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Advanced breast cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Menopause present (finding)


subject: CHEBI:25681

object_name: Menopause


subject: CHEBI:25681

object_name: Hot Flashes, CTCAE


subject: CHEBI:25681

object_name: Hot flashes


subject: UMLS:C5227743

object_name: metabolic disease


subject: UMLS:C4550206


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: meningitis


subject: CHEBI:41774

object_name: Meningitis, CTCAE


subject: CHEBI:41774

object_name: streptococcal meningitis


subject: CHEBI:41774

object_name: meningoencephalitis


subject: CHEBI:8597

subject_name: Protriptyline

object_name: Depressed mood


subject: CHEBI:8597

object_name: Cancer patients and suicide and depression


subject: CHEBI:8597

object_name: Depressed - symptom


subject: CHEBI:8597

object_name: Depression, CTCAE


subject: CHEBI:41423

subject_name: Celecoxib

object_name: osteoarthritis, hand


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Hand eczema


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic urothelial carcinoma


subject: CHEBI:72317

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:72317

object_name: Unresectable Urothelial Carcinoma


subject: CHEBI:72317

object_name: Invasive Bladder Urothelial Carcinoma with Squamous Differentiation


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB


subject: UMLS:C3896914


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Microsatellite Stable Colorectal Carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C4053637

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4053637

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:95165

object_name: T-lymphoblastic lymphoma


subject: CHEBI:50131

subject_name: Decitabine


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Acute Heart Failure Related to COVID-19


subject: UNII:349552KRHK

object_name: Acute heart failure


subject: UNII:349552KRHK

object_name: Acute non-ST segment elevation myocardial infarction (disorder)


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: DRUGBANK:DB17940

subject_name: Suvodirsen

object_name: Duchenne muscular dystrophy


subject: UMLS:C4074414

subject_name: Nuwiq

object_name: severe hemophilia A


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: abdominal abscess


subject: MESH:D000077325

object_name: morbid obesity


subject: MESH:D000077325

object_name: Hemorrhage


subject: MESH:D000077325

object_name: metabolic acidosis


subject: MESH:D000077325

object_name: acidosis


subject: MESH:D000077325

object_name: Acidosis, CTCAE


subject: MESH:D000077325

object_name: Vomiting, CTCAE


subject: MESH:D000077325

object_name: Vomiting


subject: MESH:D000077325

object_name: Reflux


subject: MESH:D000077325

object_name: Heartburn


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Refractory Lung Non-Small Cell Carcinoma


subject: UNII:6QVL057INT

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:MG94W1I5XW

subject_name: CETUXIMAB SAROTALOCAN SODIUM


subject: UNII:MG94W1I5XW

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:MG94W1I5XW

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:MG94W1I5XW

object_name: non-small cell lung carcinoma


subject: UNII:MG94W1I5XW


subject: UNII:MG94W1I5XW

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C4053596


subject: UMLS:C4053596


subject: UMLS:C4053596


subject: UMLS:C4053596


subject: UMLS:C4053596


subject: UMLS:C4053596


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: adult lymphoma


subject: UNII:15C2VL427D

object_name: lymphoma


subject: UNII:15C2VL427D

object_name: pediatric lymphoma


subject: UNII:15C2VL427D

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:4911

subject_name: Etoposide

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: complex regional pain syndrome


subject: UMLS:C1541591

subject_name: omburtamab I-131

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UMLS:C1541591

object_name: desmoplastic small round cell tumor


subject: UMLS:C1541591

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UMLS:C1541591

object_name: peritoneum cancer


subject: UMLS:C1541591

object_name: Carcinoma of peritoneum


subject: UMLS:C1541591

object_name: peritoneal carcinoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: hypertension, pregnancy-induced


subject: CHEBI:27470

object_name: proliferative diabetic retinopathy


subject: CHEBI:27470

object_name: background diabetic retinopathy


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:3021749

object_name: Severe chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: UMLS:C0591192

subject_name: Bricanyl


subject: CHEBI:9449

subject_name: Terbutaline


subject: CHEBI:2549

subject_name: Albuterol


subject: PUBCHEM.COMPOUND:2767

object_name: Homologous Recombination Deficiency


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: end stage renal failure


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: irritable bowel syndrome


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Self-Injury


subject: PUBCHEM.COMPOUND:70789204

object_name: Self-injurious behavior


subject: PUBCHEM.COMPOUND:70789204

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:70789204

object_name: autism


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:2704

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:2704

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:2704

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:2704

object_name: Breast cancer stage III


subject: CHEBI:2704

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:2704

object_name: Stage IIA Breast Carcinoma


subject: UNII:Y64GQ0KC0A

subject_name: Teprotumumab

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C2346815


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:4910

subject_name: Etomidate

object_name: mitral valve insufficiency


subject: UNII:0A6JH35GMQ

subject_name: prabotulinumtoxinA

object_name: Fanconi anemia complementation group E


subject: UMLS:C4745461

subject_name: ABP 450


subject: CHEBI:64073

object_name: hyperglycemia


subject: CHEBI:64073

object_name: Hyperglycemia, CTCAE


subject: CHEBI:64073

object_name: Glucose in blood specimen above reference range


subject: CHEBI:64073

object_name: acute coronary syndrome


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: MESH:C579565

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Locally Advanced Carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:134722

subject_name: Favipiravir

object_name: Lassa fever


subject: CHEBI:6801

subject_name: Metformin

object_name: Stargardt disease


subject: CHEBI:6801

object_name: retinal degeneration


subject: CHEBI:6801

object_name: inherited retinal dystrophy


subject: UMLS:C1676059

subject_name: TMC 278

object_name: Uses oral contraception (finding)


subject: CHEBI:68606

subject_name: Rilpivirine


subject: UMLS:C0751598

subject_name: Alferon

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Refractory Rhabdoid Tumor


subject: CHEBI:231598

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:231598

object_name: Refractory Osteosarcoma


subject: CHEBI:231598

object_name: Refractory Neuroblastoma


subject: CHEBI:231598

object_name: Refractory Langerhans Cell Histiocytosis


subject: CHEBI:231598

object_name: Refractory Childhood Malignant Germ Cell Tumor


subject: CHEBI:231598

object_name: Refractory Malignant Germ Cell Tumor


subject: CHEBI:231598

object_name: Refractory Medulloblastoma


subject: CHEBI:231598

object_name: Refractory Malignant Glioma


subject: CHEBI:231598

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:231598

object_name: Refractory Soft Tissue Sarcoma


subject: CHEBI:231598

object_name: nephroblastoma


subject: CHEBI:231598

object_name: Wilms tumor


subject: CHEBI:231598

object_name: childhood kidney Wilms tumor


subject: CHEBI:231598

object_name: Recurrent Langerhans Cell Histiocytosis


subject: CHEBI:231598

object_name: Recurrent Rhabdoid Tumor


subject: CHEBI:231598

object_name: Recurrent Malignant Germ Cell Tumor


subject: CHEBI:231598

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:231598

object_name: Refractory Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:231598

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:231598

object_name: Ewing sarcoma/peripheral primitive neuroectodermal tumor


subject: CHEBI:231598

object_name: Recurrent Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:231598

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: CHEBI:231598

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: CHEBI:231598

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: CHEBI:231598

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:231598

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:231598

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:231598

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:231598

object_name: Recurrent Soft Tissue Sarcoma


subject: CHEBI:231598

object_name: Recurrent Malignant Glioma


subject: CHEBI:231598

object_name: Ewing's sarcoma recurrent


subject: CHEBI:231598

object_name: Recurrent Medulloblastoma


subject: CHEBI:231598

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:231598

object_name: Hepatoblastoma recurrent


subject: CHEBI:231598

object_name: Neuroblastoma recurrent


subject: CHEBI:231598

object_name: Osteosarcoma recurrent


subject: CHEBI:231598

object_name: Recurrent Ependymoma


subject: CHEBI:231598

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:231598

object_name: Recurrent Glioma


subject: CHEBI:231598

object_name: low grade glioma


subject: UNII:97I1C92E55

subject_name: CEFIXIME

object_name: Syphilis female


subject: CHEBI:472657

subject_name: Cefixime


subject: PR:000001786

object_name: liver cirrhosis


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Hypoventilation


subject: UMLS:C1260201

subject_name: AMG 073

object_name: hyperparathyroidism


subject: UMLS:C1260201

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:48390

subject_name: Cinacalcet


subject: CHEBI:48390


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: binge eating


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: endogenous depression


subject: CHEBI:37941

object_name: major depressive disorder


subject: CHEBI:8499

subject_name: Propranolol

object_name: stomach disease


subject: CHEBI:73757

subject_name: Ala-Gly

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:73757

object_name: Pancreatic cancer non-resectable


subject: CHEBI:193565


subject: CHEBI:193565


subject: CHEBI:73836

subject_name: D-Ala-Gly


subject: CHEBI:73836


subject: UMLS:C1370189

subject_name: Pneumocystis jiroveci antigen


subject: UMLS:C1370189


subject: CHEBI:27569

subject_name: arabinogalactan


subject: CHEBI:27569


subject: MESH:D019081

subject_name: O Antigens


subject: MESH:D019081


subject: MESH:D000941

subject_name: Antigens


subject: MESH:D000941


subject: UMLS:C0808086

subject_name: Streptococcus pneumoniae group B Antigen


subject: UMLS:C0808086


subject: UMLS:C0808084

subject_name: Streptococcus pneumoniae group A Antigen


subject: UMLS:C0808084


subject: UMLS:C1545907

subject_name: A variant not otherwise specified Antigen


subject: UMLS:C1545907


subject: CHEBI:2654

subject_name: Aminoglutethimide


subject: CHEBI:2654


subject: CHEBI:30512

subject_name: Silver


subject: CHEBI:30512


subject: CHEBI:73788

subject_name: Ala-Gln


subject: CHEBI:73788


subject: CHEBI:49468

subject_name: Silver cation


subject: CHEBI:49468


subject: CHEBI:40618

subject_name: Pimagedine


subject: CHEBI:40618


subject: PR:000004168

subject_name: amyloid-beta precursor protein


subject: PR:000004168


subject: UMLS:C0243192

subject_name: agonists


subject: UMLS:C0243192


subject: GTOPDB:13085

subject_name: adebrelimab


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:60751

subject_name: Temoporfin

object_name: Non-small cell lung cancer stage IIIB


subject: PUBCHEM.COMPOUND:60751

object_name: Non-small cell lung cancer stage IIIA


subject: PUBCHEM.COMPOUND:60751

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:60751

object_name: stage IIB non-small cell lung cancer


subject: PUBCHEM.COMPOUND:60751

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:60751

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:60751

object_name: stage IIA non-small cell lung cancer


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Bladder transitional cell carcinoma stage I


subject: UNII:52CMI0WC3Y

object_name: Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: bladder carcinoma in situ


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: hypertriglyceridemia


subject: CHEBI:8228

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:27470

subject_name: Folic acid

object_name: pyropoikilocytosis, hereditary


subject: CHEBI:27470

object_name: hypophosphatasia


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0392927

subject_name: T4N5 liposomal lotion

object_name: precancerous condition


subject: GTOPDB:4968

subject_name: IFN-γ

object_name: myeloid leukemia


subject: GTOPDB:4968

object_name: Myelodysplasia


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C4761759

object_name: disseminated candidiasis


subject: UMLS:C4761759

object_name: candidiasis, invasive


subject: UMLS:C4761759

object_name: candidemia


subject: UMLS:C4761759

object_name: Mycoses


subject: UMLS:C4761759

object_name: Fungemia


subject: UMLS:C4761759

object_name: Fungemia, CTCAE


subject: CHEBI:229680

subject_name: Rezafungin


subject: CHEBI:229680


subject: CHEBI:229680


subject: CHEBI:229680


subject: CHEBI:229680


subject: UMLS:C2918039

subject_name: Natazia

object_name: Primary dysmenorrhea


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: Menopausal depression


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: liver failure


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: UMLS:C4053615

object_name: urothelial carcinoma


subject: UMLS:C4053615

object_name: transitional cell carcinoma


subject: UMLS:C3827115

subject_name: NY-ESO-1/GLA-SE Vaccine ID-G305

object_name: non-small cell lung carcinoma


subject: UMLS:C3827115

object_name: melanoma


subject: UMLS:C3827115

object_name: ovarian cancer


subject: UMLS:C3827115

object_name: ovarian neoplasm


subject: UMLS:C3827115

object_name: ovarian carcinoma


subject: UMLS:C3827115

object_name: Childhood Breast Carcinoma


subject: UMLS:C3827115

object_name: breast carcinoma


subject: UMLS:C3827115

object_name: breast cancer


subject: UMLS:C3827115

object_name: malignant soft tissue neoplasm


subject: UMLS:C3827115

object_name: sarcoma


subject: PUBCHEM.COMPOUND:23681189

subject_name: Acidulated Phosphate Fluoride

object_name: dentin sensitivity


subject: CHEBI:91402

subject_name: linsitinib


subject: UMLS:C2346449

subject_name: OSI 906


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: cataract


subject: HMDB:HMDB0001349

object_name: Cataract, CTCAE 3.0


subject: HMDB:HMDB0001349

object_name: Cataract, CTCAE 5.0


subject: HMDB:HMDB0001349

object_name: cataract on exam (physical finding)


subject: HMDB:HMDB0001349

object_name: macular degeneration


subject: HMDB:HMDB0001349

object_name: age-related macular degeneration


subject: HMDB:HMDB0001349

object_name: retinitis pigmentosa 30


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:119915

subject_name: Fentanyl

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:29998

subject_name: D-serine residue

object_name: psychosis


subject: CHEBI:29998

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: UMLS:C1880218

subject_name: serine, D-


subject: UMLS:C1880218


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: postpartum hemorrhage


subject: CHEMBL.COMPOUND:CHEMBL2108334

object_name: Post-partum hemorrhage


subject: UMLS:C0593103

subject_name: Novoseven


subject: UMLS:C0593103


subject: CHEBI:29354

subject_name: oxy group

object_name: opiate dependence


subject: CHEBI:15428

subject_name: Glycine


subject: UMLS:C4087028

subject_name: BET Inhibitor GSK2820151

object_name: cancer


subject: UMLS:C4087028

object_name: neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Recurrent Thyroid Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: poorly differentiated thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage III papillary thyroid cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:27732

subject_name: Caffeine

object_name: bronchopulmonary dysplasia


subject: CHEBI:27732

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: abortion in second trimester


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: lung carcinoma


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: uterine fibroid


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: urticaria


subject: PUBCHEM.COMPOUND:2735

object_name: reported urticaria (physical finding)


subject: PUBCHEM.COMPOUND:2735

object_name: Urticaria, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C2003366

subject_name: Inegy

object_name: Primary hypercholesterolemia


subject: UNII:0JD3P48M9V

object_name: hepatitis C


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Critical Illness


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:175901

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C0003448

subject_name: Antitubercular Agents

object_name: latent tuberculosis infection


subject: UMLS:C0003448

object_name: HIV infection


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Depressive Symptoms


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:7772

subject_name: omeprazole

object_name: acute coronary syndrome


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:167664

object_name: colorectal cancer


subject: CHEBI:167664

object_name: colorectal carcinoma


subject: CHEBI:167664

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:167664

object_name: neoplasm


subject: UMLS:C3641715


subject: UMLS:C3641715


subject: UMLS:C3641715


subject: UMLS:C3641715


subject: UMLS:C5555594

subject_name: Lutetium Lu-177 PNT2002

object_name: Prostatic Cancer, Castration-Resistant


subject: CHEBI:86513

object_name: Childhood Breast Carcinoma


subject: CHEBI:86513

object_name: breast carcinoma


subject: CHEBI:86513

object_name: breast cancer


subject: CHEBI:17761

subject_name: ceramide


subject: CHEBI:17761


subject: CHEBI:17761


subject: CHEBI:67027


subject: CHEBI:67027


subject: CHEBI:67027


subject: CHEBI:84701


subject: CHEBI:84701


subject: CHEBI:84701


subject: CHEBI:74100


subject: CHEBI:74100


subject: CHEBI:74100


subject: CHEBI:88431


subject: CHEBI:88431


subject: CHEBI:88431


subject: CHEBI:149661


subject: CHEBI:149661


subject: CHEBI:149661


subject: CHEBI:74450


subject: CHEBI:74450


subject: CHEBI:74450


subject: CHEBI:72965


subject: CHEBI:72965


subject: CHEBI:72965


subject: CHEBI:185212


subject: CHEBI:185212


subject: CHEBI:185212


subject: CHEBI:72959


subject: CHEBI:72959


subject: CHEBI:72959


subject: PUBCHEM.COMPOUND:53480650


subject: PUBCHEM.COMPOUND:53480650


subject: PUBCHEM.COMPOUND:53480650


subject: PUBCHEM.COMPOUND:11799850


subject: PUBCHEM.COMPOUND:11799850


subject: PUBCHEM.COMPOUND:11799850


subject: CHEBI:85261


subject: CHEBI:85261


subject: CHEBI:85261


subject: CHEBI:52639

subject_name: N-acylsphingosine


subject: CHEBI:52639


subject: CHEBI:52639


subject: PUBCHEM.COMPOUND:101853667


subject: PUBCHEM.COMPOUND:101853667


subject: PUBCHEM.COMPOUND:101853667


subject: CHEBI:34863


subject: CHEBI:34863


subject: CHEBI:34863


subject: CHEBI:134548


subject: CHEBI:134548


subject: CHEBI:134548


subject: CHEBI:67045


subject: CHEBI:67045


subject: CHEBI:67045


subject: CHEBI:52962


subject: CHEBI:52962


subject: CHEBI:52962


subject: CHEBI:172405


subject: CHEBI:172405


subject: CHEBI:172405


subject: CHEBI:149633


subject: CHEBI:149633


subject: CHEBI:149633


subject: CHEBI:72968


subject: CHEBI:72968


subject: CHEBI:72968


subject: CHEBI:67021


subject: CHEBI:67021


subject: CHEBI:67021


subject: CHEBI:72962


subject: CHEBI:72962


subject: CHEBI:72962


subject: CHEBI:74132


subject: CHEBI:74132


subject: CHEBI:74132


subject: CHEBI:77996

subject_name: N-oleoylsphingosine


subject: CHEBI:77996


subject: CHEBI:77996


subject: CHEBI:72966


subject: CHEBI:72966


subject: CHEBI:72966


subject: CHEBI:187785


subject: CHEBI:187785


subject: CHEBI:187785


subject: CHEBI:88426


subject: CHEBI:88426


subject: CHEBI:88426


subject: CHEBI:52961


subject: CHEBI:52961


subject: CHEBI:52961


subject: CHEBI:72956


subject: CHEBI:72956


subject: CHEBI:72956


subject: PUBCHEM.COMPOUND:10627306


subject: PUBCHEM.COMPOUND:10627306


subject: PUBCHEM.COMPOUND:10627306


subject: CHEBI:74130


subject: CHEBI:74130


subject: CHEBI:74130


subject: CHEBI:67042


subject: CHEBI:67042


subject: CHEBI:67042


subject: CHEBI:233680


subject: CHEBI:233680


subject: CHEBI:233680


subject: CHEBI:84372


subject: CHEBI:84372


subject: CHEBI:84372


subject: CHEBI:88888

subject_name: 3-Sulfodeoxycholic acid


subject: CHEBI:88888


subject: CHEBI:88888


subject: CHEBI:72961


subject: CHEBI:72961


subject: CHEBI:72961


subject: CHEBI:67033

subject_name: Ceramide NG


subject: CHEBI:67033


subject: CHEBI:67033


subject: MESH:C000720457

object_name: asthma


subject: UMLS:C1710686

object_name: thyroid gland papillary carcinoma


subject: UMLS:C1710686

object_name: thyroid gland follicular carcinoma


subject: UMLS:C1710686

object_name: thyroid cancer, nonmedullary, 2


subject: UMLS:C1710686

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C1710686

object_name: clear cell renal carcinoma


subject: UMLS:C1710686

object_name: renal cell adenocarcinoma


subject: UMLS:C1710686

object_name: renal cell carcinoma


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:68534

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:68534

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:68534

object_name: malignant neoplasm of breast stage I


subject: CHEBI:68534

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:68534

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:68534

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:68534

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:68534

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:68534

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:68534

object_name: invasive breast carcinoma


subject: CHEBI:30145

subject_name: lithium atom

object_name: Aggressive behavior


subject: CHEBI:30145

object_name: Aggression


subject: CHEBI:30145

object_name: conduct disorder


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: chronic pain (diagnosis)


subject: PUBCHEM.COMPOUND:9848990

object_name: Chronic pain


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:71219

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: coronary artery disorder


subject: CHEBI:3127

object_name: coronary atherosclerosis


subject: CHEBI:3127

object_name: post-operative atrial fibrillation


subject: UMLS:C0733742

subject_name: Minisiston

object_name: Uses contraception (finding)


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Compensated hypothyroidism


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: iron deficiency anemia


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:33313

subject_name: polonium atom


subject: CHEBI:33313


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: migraine


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:47781

subject_name: Desipramine

object_name: impotence


subject: CHEBI:47781

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:47781

object_name: Erectile dysfunction


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:63632

subject_name: Topotecan

object_name: COVID-19 respiratory infection


subject: CHEBI:91872

object_name: mediastinal cancer


subject: CHEBI:91872

object_name: neoplasm of mediastinum


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: anaplastic large cell lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Burkitt lymphoma


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378

object_name: lymphoblastic lymphoma


subject: CHEBI:8378

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:8378

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:8378


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: B-cell acute lymphoblastic leukemia


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932